Showing results (351-360 of 420) with videos related to
Sort By:
Pageof 42
Journal of the American College of Nutrition|October 1, 1992
Effect of interleukin-2 on some micronutrients during adoptive immunotherapy for various cancersH Baker, S L Marcus, D P Petrylak, et al.Cancer Research|December 29, 1998
Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cellsD C Zhou, S J Hallam, S J Lee, et al.Antimicrobial Agents and Chemotherapy|March 1, 1979
Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patientsJ F Bender, S C Schimpff, V M Young, et al.Cancer Treatment Reports|July 1, 1983
Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinomaR S Aroney, J Aisner, M N Wesley, et al.Antimicrobial Agents and Chemotherapy|August 1, 1980
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.American Journal of Hematology|April 3, 2001
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneityE Paietta, D Neuberg, S Richards, et al.Cancer|June 15, 1984
Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcomaH Gerad, D A van Echo, M Whitacre, et al.Cancer Treatment Reports|January 1, 1981
High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicityS Ostrow, M J Egorin, D Hahn, et al.JAMA|July 10, 1981
Two methods for improved venous access in acute leukemia patientsJ C Wade, K A Newman, S C Schimpff, et al.Leukemia|August 15, 2000
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)C Robles, K M Kim, M M Oken, et al.Pageof 42